FUJIFILM Completes Acquisition of Hitachi’s Medical Imaging Business to Deliver Integrated Healthcare Solutions

Fujifilm Corporation announced that it completed the acquisition of Hitachi, Ltd.’s (hereinafter referred to as “Hitachi”) diagnostic imaging-related businesses on March 31, 2021. This marks the official launch of “Fujifilm Healthcare,” a new company established by Hitachi to succeed these operations, which has now become a wholly owned subsidiary of the Fujifilm Group.

In recent years, healthcare institutions have increasingly preferred suppliers that can provide integrated solutions directly contributing to their operational management, requiring the combination of various products. Through this acquisition, Fujifilm’s medical business has expanded its product portfolio to include CT, MRI, X-ray imaging systems, ultrasound diagnostic equipment, endoscopes, in vitro diagnostic systems, and PACS. This expansion enables the company to offer one-stop, comprehensive solutions tailored to the actual needs of healthcare institutions. In the future, we will integrate these products with Fujifilm’s advanced image processing and artificial intelligence technologies, focusing on medical IT to deliver higher value-added solutions globally.

Following the integration of Fujifilm Healthcare Corporation as a subsidiary, the Fujifilm Group will further expand its medical systems business to drive overall growth in the healthcare sector. By leveraging the Group’s technologies, products, and services, it aims to deliver more comprehensive, high-quality solutions, thereby contributing to the advancement of medical care and the maintenance and improvement of people’s health and well-being.

[Overview of FUJIFILM Healthcare Corporation] (as of March 31, 2021)

Composed of two core business units, FUJIFILM Corporation and Fuji Xerox Co., Ltd., the group comprises 317 subsidiaries worldwide and employs more than 74,000 people. For the fiscal year 2019, total sales amounted to approximately USD 21.239 billion, with operating profit reaching approximately USD 1.712 billion.

Fujifilm (China) Investment Co., Ltd.: The overarching entity for Fujifilm Corporation’s operations in China, established on April 12, 2001, with its headquarters in Shanghai. Its business areas include digital cameras, imaging products, printing products, medical products, optoelectronic products, and industrial materials, with a registered capital of USD 213.4 million (as of March 2020).